Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent

M.W.J. den Brok; B. Nuijen; C. Lutz; H.G. Opitz; J.H. Beijnen

Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent

M.W.J. den Brok
, B. Nuijen
, C. Lutz
, H.G. Opitz
, J.H. Beijnen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1101-1114
Number of pages	14
Journal	Journal of Pharmaceutical Sciences
Volume	94
Issue number	5
Publication status	Published - 2005

Cite this

@article{bd162f4c281040f595cbbef93652aeb5,

title = "Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent",

author = "\{den Brok\}, M.W.J. and B. Nuijen and C. Lutz and H.G. Opitz and J.H. Beijnen",

year = "2005",

language = "Undefined/Unknown",

volume = "94",

pages = "1101--1114",

journal = "Journal of Pharmaceutical Sciences",

issn = "0022-3549",

publisher = "Elsevier BV",

number = "5",

}

Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent. / den Brok, M.W.J.; Nuijen, B.; Lutz, C. et al.
In: Journal of Pharmaceutical Sciences, Vol. 94, No. 5, 2005, p. 1101-1114.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent

AU - den Brok, M.W.J.

AU - Nuijen, B.

AU - Lutz, C.

AU - Opitz, H.G.

AU - Beijnen, J.H.

PY - 2005

Y1 - 2005

M3 - Article

SN - 0022-3549

VL - 94

SP - 1101

EP - 1114

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

IS - 5

ER -